Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managin...
Схожі ресурси
Схожі ресурси
-
Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
за авторством: Claudia Crimi, та інші
Опубліковано: (2023-11-01) -
Nasal polyps impact in severe asthma patients: evidences from the SANI
за авторством: Giorgio Walter Canonica, та інші
Опубліковано: (2020-08-01) -
Economic impact of a more extensive use of FENO testing on the Italian population with asthma
за авторством: Carla Rognoni, та інші
Опубліковано: (2023-06-01) -
Asthma severity: the patient’s point of view
за авторством: Gabriella Guarnieri, та інші
Опубліковано: (2024-12-01) -
Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers
за авторством: Giovanna Elisiana Carpagnano, та інші
Опубліковано: (2023-10-01)